NCT02558088已完成4 期
Pharmacological Properties of Inhaled Salmeterol in Healthy Trained Males
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 11
- 试验地点
- 1
- 主要终点
- Urine concentration of salmeterol
研究概览
简要总结
The objective of the study is to help establish a urinary threshold for salmeterol on the World Anti-doping Agency prohibited list, to avoid supratherapeutic of this substance in competitive sports.
Hence, there is no hypothesis as such.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •18-45 years
排除标准
- •Chronic disease
- •Habitual use of medicine
- •Allergy towards salmeterol
- •Unable to exercise on a bike ergometer
研究组 & 干预措施
salmeterol
Experimental
干预措施: Salmeterol (Drug)
结局指标
主要结局
Urine concentration of salmeterol
时间窗: 0-24 hours after administration of the study drug
次要结局
未报告次要终点
研究者
Morten Nielsen
MSc.
University of Copenhagen
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Urinary Concentration After SalmeterolHealthyNCT06657547University of Copenhagen24
Unknown
4 期
Concentrations of Salmeterol in Blood and UrineAsthmaNCT00914901Bispebjerg Hospital30
进行中（未招募）
1 期
ptake and excretion of salmeterol in healthy trained malesEUCTR2014-002139-33-DKBispebjerg University Hospital
已完成
不适用
The Effect of Inhaled Salmeterol on Inflammation after Bronchial Instillation of Allergen or Allergen/Lipopolysaccharide in Asthma.Mild asthma, allergen induced inflammationNL-OMON26298Academic Medical Center Amsterdam, dept. Pulmonology32
已完成
4 期
Investigation of inhaled Salmeterol/ Fluticasone propionate (SFC) in patient with COPD.Chronic obstructive pulmonary diseaseJPRN-UMIN000006589Hamamatsu University School of Medicine342